Trial intelligence / Profile preview

High Dose Oral vs IV Esomeprazole for Bleeding Peptic Ulcers

NCT00164788Phase 2Terminated

Sponsor
The Chinese University of Hong Kong
Start
Jul 2004
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of esomeprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Median gastric pH over 24-hour monitoring. Started Jul 2004; status: terminated.

02

Drugs

esomeprazole
03

Conditions

Peptic ulcer hemorrhage (PUB)

Beyond the preview

Go deeper on NCT00164788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00164788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call